UK 11:41 Monday, 12 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Hello, Share Choosers. You may not be familiar with medical mover Clinigen (CLIN). But this sparky company might interest those who support improving access to treatments picking the right pharma-related stocks. It’s an outfit which specialises in finding, storing and selling treatments which can be hard to access. It also funds clinical trials, which has to be a good use of your dosh. The firm works with more than 6,000 pharmacists and pharma companies across the globe.
Hello, Share Dabblers. Here’s another AIM company which might actually be worth investing in. Clinigen (CLIN) is a medicines distributor. And, as the world seems to be moving towards older and sicker, the market is likely to expand. And there’s nothing better for share price prospects than an expanding market.
From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2016 and thus far in 2017 (by net short position %) - and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...
From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2016 and thus far in 2017 (by net short position %) - and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...
Today’s second Bull Call, Clinigen, consists of what you might expect as far as a decent up trend situation, with the year to date generally witnessing a procession within a rising price channel, one which has been in place since the beginning of the year.
